Novel paramagnetic AT1 receptor antagonists.
Tan, Nichole P H; Taylor, Michelle K; Bottle, Steven E; Wright, Christine E; Ziogas, James; White, Jonathan M; Schiesser, Carl H; Jani, Nitya V.
Chem Commun (Camb)
; 47(44): 12083-5, 2011 Nov 28.
Artigo em Inglês | MEDLINE | ID: mdl-21963998
Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect.
[Contemporary pharmacotherapy of arterial hypertension in medical personnel].
Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Heart failure drug treatment.
Validation of Brain Angiotensin System Blockade as a Novel Drug Target in Pharmacological Treatment of Neuropsychiatric Disorders.
Preoperative renin-angiotensin system inhibitors use linked to reduced acute kidney injury: a systematic review and meta-analysis.
Antihypertensive efficacy and safety of the angiotensin receptor blocker azilsartan in elderly patients with hypertension.
The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences.
Bone mineral density is reduced by telmisartan in male spontaneously hypertensive rats.
Role of CD2-associated protein in podocyte apoptosis and proteinuria induced by angiotensin II.